These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21647401)

  • 1. Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?
    Culina S; Boitard C; Mallone R
    Clin Dev Immunol; 2011; 2011():286248. PubMed ID: 21647401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
    J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.
    Liblau R; Tisch R; Bercovici N; McDevitt HO
    Immunol Today; 1997 Dec; 18(12):599-604. PubMed ID: 9425739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.
    Odegard JM; Nepom GT; Wambre E
    Clin Immunol; 2015 Nov; 161(1):44-50. PubMed ID: 26122171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-based therapy for the treatment of type 1 diabetes.
    Tian J; Kaufman DL
    Diabetes; 2009 Sep; 58(9):1939-46. PubMed ID: 19720821
    [No Abstract]   [Full Text] [Related]  

  • 8. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
    Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for immune intervention trials in type 1 diabetes.
    Mallone R; Roep BO
    Clin Immunol; 2013 Dec; 149(3):286-96. PubMed ID: 23510725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
    Boitard C
    Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active suppression of diabetes after oral administration of insulin is determined by antigen dosage.
    Bergerot I; Fabien N; Mayer A; Thivolet C
    Ann N Y Acad Sci; 1996 Feb; 778():362-7. PubMed ID: 8610991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
    Smith EL; Peakman M
    Front Immunol; 2018; 9():392. PubMed ID: 29541078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells and type 1 diabetes ...in mice and men.
    Hinman RM; Smith MJ; Cambier JC
    Immunol Lett; 2014 Aug; 160(2):128-32. PubMed ID: 24472603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
    Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
    PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.
    Driver JP; Serreze DV; Chen YG
    Semin Immunopathol; 2011 Jan; 33(1):67-87. PubMed ID: 20424843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.
    Dai YD; Sheng H; Dias P; Jubayer Rahman M; Bashratyan R; Regn D; Marquardt K
    Curr Diab Rep; 2017 Oct; 17(12):130. PubMed ID: 29080983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
    Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
    J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of dendritic cells in the therapy of Type 1 diabetes.
    Lee CN; Lew AM; Wu L
    Immunotherapy; 2013 Jun; 5(6):591-606. PubMed ID: 23725283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
    You S; Chatenoud L
    Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.